SPIA
FBIO icon

Steward Partners Investment Advisory’s Fortress Biotech FBIO Stock Holding History

Steward Partners Investment Advisory’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$279 – 4736
2026
Q1 		$279 Sell
100
-2,300
-96% -$7.82K ﹤0.01% 4298
2025
Q4 		$8.78K Sell
2,400
-4,400
-65% -$12.5K ﹤0.01% 3493
2025
Q3 		$25.1K Buy
+6,800
New +$17.2K ﹤0.01% 2977
2022
Q1 		– Sell
-218
Closed -$8K – 3310
2021
Q4 		$8K Sell
218
-21
-9% -$937 ﹤0.01% 2681
2021
Q3 		$12K Buy
239
+34
+17% +$1.66K ﹤0.01% 2536
2021
Q2 		$11K Sell
205
-128
-38% -$7.72K ﹤0.01% 5856
2021
Q1 		$17.6K Buy
+333
New +$18.8K ﹤0.01% 2535

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Steward Partners Investment Advisory's FBIO Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Fortress Biotech (FBIO) in Q2 2026, closing a stake of 100 shares — an estimated $279 sold.

Steward Partners Investment Advisory first reported a position in FBIO in Q1 2021 and held it in 7 quarters. The position peaked at $25.1K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Steward Partners Investment Advisory reported no remaining Fortress Biotech position as of Q2 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 100 Fortress Biotech shares in Q2 2026, an estimated $279.
  • Steward Partners Investment Advisory first reported a position in Fortress Biotech in Q1 2021 and held it in 7 quarters.
  • Steward Partners Investment Advisory's Fortress Biotech position peaked at $25.1K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.